PNC Financial Services Group
IDIX

PNC Financial Services Group’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

PNC Financial Services Group’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-356
Closed -$9K – 4129
2014
Q2 		$9K Buy
356
+29
+9% +$302 ﹤0.01% 3170
2014
Q1 		$2K Buy
+327
New +$2.28K ﹤0.01% 3618
2013
Q4 		– Sell
-18,320
Closed -$96K – 3768
2013
Q3 		$96K Hold
18,320
– – ﹤0.01% 2195
2013
Q2 		$66K Buy
+18,320
New +$74.9K ﹤0.01% 2280

PNC Financial Services Group's IDIX Position: Q3 2014 in Review

PNC Financial Services Group sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 356 shares — an estimated $9K sold.

PNC Financial Services Group first reported a position in IDIX in Q2 2013 and held it in 4 quarters. The position peaked at $96K in Q3 2013. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • PNC Financial Services Group reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • PNC Financial Services Group sold 356 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $9K.
  • PNC Financial Services Group first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • PNC Financial Services Group's IDENIX PHARMACEUTICALS INC position peaked at $96K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on PNC Financial Services Group's 13F filing for Q3 2014, filed 7 Nov 2014.